19 March 2020
: Case report
Emergent Phenol Injection of Bilateral Stellate Ganglion for Management of Refractory Malignant Ventricular Arrhythmias
Unusual or unexpected effect of treatment
Whitney R. Luke1ABCDEF, Emile G. Daoud2ABCDEF*, Omar S. Latif2ABCDEFDOI: 10.12659/AJCR.921465
Am J Case Rep 2020; 21:e921465
Abstract
BACKGROUND: Management of incessant electrical storm is poorly defined. These 2 case studies demonstrate a simplified percutaneous approach to achieve stellate ganglion ablation (SGA) and to promptly control malignant ventricular arrhythmias.
CASE REPORT: This report describes 2 patients with deteriorating hemodynamics, progressive ventricular arrhythmias, and worsening heart failure, managed with emergent percutaneous fluoroscopically-guided bilateral SGA to achieve bilateral cardiac sympathetic denervation. While supine and intubated, the left and then right stellate ganglion were identified guided by anatomic landmarks. Using a 22-guage, 3.5-inch spinal needle, contrast dye was injected with appropriate outline of the stellate ganglion at the uncinate process of the C6 vertebra. Bupivacaine 0.5% was injected, followed by phenol 6%. Successful SGA was confirmed by intentional Horner’s syndrome with bilateral eye lag. The procedures were completed in about 30 min without complications and there was a dramatic reduction in ventricular arrhythmias.
CONCLUSIONS: Emergent percutaneous bilateral SGA can be accomplished with a brief procedure resulting in management of electrical storm.
Keywords: Stellate Ganglion, Sympathectomy, Chemical, Tachycardia, Ventricular, Ablation Techniques, Bupivacaine, Fluoroscopy, Injections, Phenol
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946551
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945265
Most Viewed Current Articles
21 Jun 2024 : Case report
94,336
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,457
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,658
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,129
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030